Selected References:
- Boutroy MJ, et al. 1988. Clonidine: Placental transfer and neonatal adaption. Early Hum Dev 17:275-286.
- Bunjes R, Schaefer C. 1993. Clonidine and breast-feeding. Clinical Pharm 12:178-9.
- Frazier, LM, et al. 2020. Emerging therapies for the treatment of neonatal abstinence syndrome. The Journal of Maternal-Fetal & Neonatal Medicine 6:1-9.
- Horvath JS, et al. 1985. Clonidine hydrochloride a safe and effective antihypertensive agent in pregnancy. Obstet Gynecol 66:634-8.
- Huisjes, et al. 1986. Is clonidine a behavioural teratogen in the human? Early Hum Dev 14:43-8.
- Khan A, et al. 1970. Clonidine (Catapres): a new anti-hypertensive agent. Cur Ther Res 12:10.
- Mirmiran M. 1986. The importance of fetal/neonatal REM sleep. Eur J Obstet Gynecol Reprod Biol 21:283-91.
- Rothberger S, et al. 2010. Pharmacodynamics of clonidine therapy in pregnancy: a heterogeneous maternal response impacts fetal growth. Am J Hypertens. 23(11):1234-40.
- Sevrez C, et al. 2014. [Transplacental or breast milk intoxication to clonidine: a case of neonatal hypotonia and drowsiness]. Arch Pediatr. 21(2):198-200.
- Stoll C, et al. 1979. Robert’s syndrome and clonidine. J Med Genet 16:486-8.
- Tsai TH, et al. 1982. Teratologic and reproductive studies of lofexidine. Arzneimittelforsh 32:962-6.
